Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

X-82 to Treat Age-related Macular Degeneration

ClinicalTrials.gov ID: NCT02348359

Public ClinicalTrials.gov record NCT02348359. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 7:34 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Masked, Placebo-Controlled, Dose- Finding, Non-Inferiority Study of X-82 Plus Prn Intravitreal (Ivt) Anti-VEGF Compared to Prn Ivt Anti-VEGF Monotherapy in Neovascular AMD

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the safety and efficacy of X-82 in the treatment of vision loss due to wet AMD.

Study identification

NCT ID
NCT02348359
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Tyrogenex
Industry
Enrollment
157 participants

Conditions and interventions

Eligibility (public fields only)

Age range
50 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 16, 2015 (Actual)
Primary completion
Dec 12, 2017 (Actual)
Completion
Jan 12, 2018 (Actual)
Last update posted
Feb 11, 2022

2015 – 2018

United States locations

U.S. sites
35
U.S. states
18
U.S. cities
35
Facility City State ZIP Site status
Not listed Tucson Arizona — —
Not listed Beverly Hills California — —
Not listed Huntington Beach California — —
Not listed Redlands California — —
Not listed Sacramento California — —
Not listed Colorado Springs Colorado — —
Not listed Golden Colorado — —
Not listed New London Connecticut — —
Not listed Fort Myers Florida — —
Not listed Lakeland Florida — —
Not listed Melbourne Florida — —
Not listed Miami Florida — —
Not listed Palm Beach Gardens Florida — —
Not listed Augusta Georgia — —
Not listed Lemont Illinois — —
Not listed Oak Forest Illinois — —
Not listed Indianapolis Indiana — —
Not listed Baltimore Maryland — —
Not listed Glen Burnie Maryland — —
Not listed Boston Massachusetts — —
Not listed Springfield Massachusetts — —
Not listed Portsmouth New Hampshire — —
Not listed Bloomfield New Jersey — —
Not listed Albany New York — —
Not listed New York New York — —
Not listed Asheville North Carolina — —
Not listed Charlotte North Carolina — —
Not listed Cleveland Ohio — —
Not listed Youngstown Ohio — —
Not listed Nashville Tennessee — —
Not listed Abilene Texas — —
Not listed Austin Texas — —
Not listed Houston Texas — —
Not listed The Woodlands Texas — —
Not listed Richmond Virginia — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02348359, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 11, 2022 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02348359 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →